greeksoup/ stock research

Repligen (RGEN) Q3 FY2025 earnings: revenue $189 million, up 21.9% on the year

Repligen Corp. (RGEN) reported revenue of $189 million for Q3 FY2025, the quarter ended 30 September 2025, up 21.9% on the same quarter a year earlier. Net income was $15 million, and diluted earnings per share $0.26. The figures are the company's own, from the 10-Q it filed with the SEC on 4 November 2025.

Revenue$189 millionup 21.9%
Net income$15 million
Diluted EPS$0.26
QuarterQ3 FY2025ended 30 September 2025

The quarter, against the one before and a year earlier

LineQ3 FY2025Q2 FY2025Q3 FY2024Change on the year
Revenue189182155+21.9%
Cost of revenue88.389.477.4+14.1%
Gross profit10193.077.5+29.7%
Gross margin53.2%51.0%50.0%
Research and development14.214.09.7+46.0%
Selling, general and administrative73.770.975.6-2.6%
Operating income16.813.9-7.8n/a
Operating margin8.9%7.6%-5.1%
Interest expense5.45.45.1+5.7%
Pre-tax income17.118.2-1.1n/a
Income tax2.23.3-0.5n/a
Effective tax rate12.9%18.4%n/a
Net income14.914.9-0.7n/a
Net margin7.9%8.2%-0.4%
Diluted EPS$0.26$0.26-$0.01n/a
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed.

Cash flow and capital returned

LineQ3 FY2025Q2 FY2025Q3 FY2024Change on the year
Operating cash flow48.128.649.3-2.5%
Capital expenditure4.77.17.0-32.7%
Free cash flow43.421.542.3+2.5%
Free cash flow margin23.0%11.8%27.3%
Cash from investing-7.8-7.8-5.9n/a
Cash from financing-0.2-10.1-69.6n/a
Depreciation and amortisation20.020.117.7+13.3%
Share-based compensation9.08.423.1-61.1%
Diluted shares, weighted57m57m56m+0.9%
Shares outstanding at period end56m56m56m+0.5%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ3 FY2025Q2 FY2025Q3 FY2024Change on the year
Shareholders' equity2,0832,0622,017+3.3%
Debt538534522+3.1%
Operating lease liabilities132136139-5.1%
Other liabilities171170154+11.3%
Total liabilities and equity2,9242,9022,831+3.3%
Fixed assets189193203-6.7%
Goodwill1,1131,114988+12.7%
Intangible assets395406381+3.9%
Cash and equivalents749709784-4.5%
Receivables149157129+15.5%
Inventory160156182-12.1%
Other assets169166164+2.6%
Total assets2,9242,9022,831+3.3%

Quarterly results, the last 12 quarters

Q3 FY2023 †Q4 FY2023 * †Q1 FY2024 †Q2 FY2024 †Q3 FY2024Q4 FY2024 * †Q1 FY2025 †Q2 FY2025 †Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue141167153159155168169182189198194204
Cost of revenue10588.176.477.377.412977.889.488.394.186.094.1
Gross profit36.678.576.881.577.538.891.493.0101104108110
Gross margin26%47%50%51%50%23%54%51%53%52%56%54%
R&D10.610.311.210.69.711.712.114.014.213.114.514.4
SG&A55.657.661.765.575.660.670.770.973.774.476.576.6
Operating income4.79.93.85.5-7.8-36.56.613.916.817.915.914.0
Operating margin3%6%2%3%-5%-22%4%8%9%9%8%7%
Interest expense0.31.14.95.05.15.55.25.45.45.55.65.7
Pre-tax income11.41.93.79.0-1.1-38.67.918.217.119.11.814.2
Tax rate-49%982%11%37%n/an/a27%18%13%30%-370%65%
Net income16.9-16.43.35.7-0.7-33.95.814.914.913.38.35.0
Net margin12%-10%2%4%-0%-20%3%8%8%7%4%2%
Diluted EPS$0.32-$0.46$0.04$0.06-$0.01-$0.60$0.10$0.26$0.26$0.23$0.15$0.09
Operating cash flow39.229.144.742.249.339.215.028.648.125.728.332.8
Capital expenditure8.411.18.34.87.05.53.67.14.78.24.75.3
Free cash flow30.818.036.437.442.333.611.421.543.417.623.627.4
Shares outstanding56m56m56m56m56m56m56m56m56m56m56m56m
Filing10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS and diluted share count are from the company's results press release for that quarter, used where the release gives the same revenue and net income as the table. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-Q for the period ended 30 September 2025, filed 4 November 2025, accession 0001193125-25-264666: the filing on EDGAR. All of Repligen Corp.'s filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install